Data / Form D filings / Salerno Pharmaceuticals, LP
Salerno Pharmaceuticals, LP: Form D filings
Salerno Pharmaceuticals, LP, a pharmaceuticals company in Newport Beach, CA, filed 3 Form D notices with the SEC between 2017 and 2019. The latest, on July 31, 2019, reports $625,437 sold of a $1.8 million offering to 11 investors.
Find out what Salerno Pharmaceuticals, LP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 610 NEWPORT CENTER DRIVE, SUITE 330, Newport Beach, CA, 92660
- Phone
- (949) 706-3600
- Industry
- Pharmaceuticals
- Entity type
- Limited Partnership
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1694399
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 31, 2019 | New notice | $1,831,692 | $625,437 | $1,206,255 | 11 | Jul 19, 2019 | sec.gov |
| Feb 27, 2017 | Amendment | $5,493,236 | $5,493,236 | $0 | 41 | Feb 16, 2017 | sec.gov |
| Jan 13, 2017 | New notice | $5,000,000 | $2,960,000 | $2,040,000 | 19 | Dec 30, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Edward W. McKenna | Executive Officer | |
| Thomas W. Courtney, Jr. | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jul 29, 2019 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Salerno Pharmaceuticals, LP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.